Optimization and Refinement of Technique in In-Office Sinus Dilation 2

Optimization and Refinement of Technique in In-Office Sinus Dilation 2 (ORIOS 2)

A prospective, multi-arm, multi-center, observational post-market study of balloon sinus dilatation in the physician office setting under local anesthesia to treat patients with chronic rhinosinusitis (CRS). All products intended for use in this study have been FDA cleared for sale in the U.S.A.

Inclusion Criteria:

• Male/Female, 18 year or older
• Diagnosis of Chronic Rhinosinusitis
• Planned Endoscopic Sinus surgery

Exclusion Criteria:

• Cystic Fibrosis
• Severe Polyposis
• Sinonasal tumors
• History of facial trauma precluding access to sinus ostium
• Ciliary Disfunction
• Planned non-sinus surgery (such as rhinoplasty, septoplasty, etc.)
• Pregnant or lactating female
• Inability to tolerate an awake procedure
• Participation in another investigational clinical study involving treatment for chronic rhinosinusitis